Best pharmacological practice: urinary tract infections

Area of Science:

• Infectious Diseases
• Microbiology
• Pharmacology

Background:

• Urinary tract infections (UTIs) represent the most common bacterial infections globally.
• Acute uncomplicated UTIs and pyelonephritis primarily affect young women with healthy genitourinary systems.
• Antimicrobial resistance necessitates ongoing evaluation of optimal treatment strategies for UTIs.

Purpose of the Study:

• To review current management strategies for acute uncomplicated cystitis and acute non-obstructive pyelonephritis.
• To assess the efficacy and resistance patterns of various antimicrobial agents used for UTIs.
• To provide guidance on appropriate antimicrobial selection for different UTI classifications.

Main Methods:

• Literature review of current guidelines and resistance data for UTI management.
• Analysis of antimicrobial susceptibility trends for common UTI pathogens.
• Evaluation of treatment recommendations for uncomplicated cystitis, pyelonephritis, and complicated UTIs.

Main Results:

• Increasing resistance to trimethoprim and trimethoprim/sulfamethoxazole is observed for acute cystitis.
• Pivmecillinam, nitrofurantoin, and fosfomycin trometamol are emerging as preferred agents for uncomplicated cystitis.
• Flouroquinolones remain effective for acute pyelonephritis but should be used judiciously to mitigate resistance.

Conclusions:

• Antimicrobial selection for acute cystitis must adapt to rising resistance patterns.
• Flouroquinolones are recommended for acute pyelonephritis, with therapy guided by culture results.
• Complicated UTIs require individualized treatment, and asymptomatic bacteriuria generally does not warrant treatment.